Clinical Trial Update: Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 [Phase 2]

View source ↗

Summary

Completion of a Phase 2 roll-over trial evaluating LCI699 (osilodrostat) in patients with endogenous Cushing's syndrome. Results for the study were posted in De…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Syndrome

Drugs mentioned

• LCI699/osilodrostat (osilodrostat)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Cushing's Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2024-12-18